ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00301834
Brief Title: Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders

First Submitted : March 9, 2006
First Submitted that Met QC Criteria : March 9, 2006
First Posted : March 13, 2006 (Estimate)

Results First Submitted : January 31, 2013
Results First Submitted that Met QC Criteria : April 22, 2013
Results First Posted : May 16, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : August 30, 2017
Last Update Posted : September 28, 2017